Michael Nordtvedt

Wilson Sonsini Goodrich & Rosati

+ Follow Contact

Latest Posts › Securities

Share:

2024 Technology and Life Sciences IPO Report

Wilson Sonsini's 2024 Technology and Life Sciences IPO Report provides in-depth analysis on 33 initial public offerings (IPOs) completed by U.S.-based technology and life sciences companies in 2024 with deal values exceeding...more

2/28/2025 / Capital Markets , Financial Services Industry , Initial Public Offering (IPO) , Investment , Life Sciences , Publicly-Traded Companies , Securities , Securities and Exchange Commission (SEC) , Securities Regulation , Technology Sector

Looking Ahead to T+1 Settlement for Broker-Dealer Securities Transactions

Beginning May 28, 2024, the standard settlement cycle for most broker-dealer securities transactions will be one business day (T+1) following a trade instead of two business days (T+2), which has been the standard since 2017....more

5/21/2024 / Broker-Dealer , Compliance , Investment Adviser , Securities , Securities and Exchange Commission (SEC) , Securities Exchange Act , Securities Traders , Securities Transactions

2023 Technology and Life Sciences PIPE and RDO Report

The 2023 Technology and Life Sciences PIPE and RDO Report presents analysis related to 177 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences...more

2/23/2024 / Capital Markets , Fiduciary Duty , Initial Public Offering (IPO) , Investors , Life Sciences , Private Investment in Public Equity (PIPEs) , Rule 10b-5 , Securities , Shareholders , Technology Sector

3 Results

View per page

Page: of 1